Project Grant HT94252410304
Award Date 6/1/24
Completion Date 5/31/28
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,001 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer,"...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $723,456 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research investigating the role of parkin-mediated mitophagy in susceptibility and resilience to mitochondrial toxicant exposures. This three-year research initiative will be conducted at UAB's Birmingham, Alabama...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $650,845 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award, which began July 1, 2025, and extends through June 30, 2028, supports advanced biomedical research aimed at identifying and validating diagnostic tools to improve...
- Federal Project Grant Summary The University of Alabama at Birmingham received a $1,317,584 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. This research initiative focuses on developing macrophage-centric prognostic biomarkers to improve outcomes for checkpoint blockade immunotherapy in melanoma treatment. The three-year project will advance biomedical research...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $516,779 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. This award funds research investigating the relationship between dystrophin restoration in the brain and circadian rhythm recovery as potential therapeutic interventions for Duchenne muscular dystrophy (DMD) symptoms. The research...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $227,167 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2028. The research project, titled "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma," focuses on developing and validating diagnostic biomarkers to improve patient...
- The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...